Forschungsprojekte
Ergebnisse pro Seite:
10
2018 - 2020
Bedeutung von Serum in der GVHD-Entstehung- Dr. Eva Maria Wagner-Drouet,
- Dr. Pascal Wölfinger
2017 - 2021
Identifizierung und immuntherapeutische Charakterisierung Tumorassoziierter Antigene und Neoantigene in genetischen und karzinogen-induzierten Melanom Tumormodellen- Univ.-Prof. Dr. Hansjörg Schild,
- Dr. Mustafa Diken
2017 - 2021
Proteine auf Nanocarriern: vom Stealth Effekt zu einem gezielten Targeting in vivo- Univ.-Prof. Dr. Stefan Tenzer,
- Prof. Dr. Tanja Weil,
- Prof. Dr. Volker Mailänder
2017 - 2021
Polymer-mediated tumor immunotherapy by in situ activation of antigen-presenting cells- Dr. Lutz Nuhn,
- Univ.-Prof. Dr. Hansjörg Schild,
- Univ.-Prof. Dr. Stephan Grabbe
2017 - 2021
Development and testing of nanoparticles for inhibition of cAMP-mediated immunosuppression of malignant melanoma- Dr. Matthias Barz,
- PD Dr. Christian Becker,
- Univ.-Prof. Dr. Tobias Bopp
2017 - 2020
Thiol switches controlled by the glutathione-S-transferase GDAP1- Univ.-Prof. Dr. Stefan Tenzer
2017 - 2018
Integrierte Multi-Omics Analyse zur Aufklärung von Tumor-Pathomechanismen- Univ.-Prof. Dr. Tobias Bopp,
- Univ.-Prof. Dr. Stefan Tenzer
2017 - 2021
Multifunctional nanoscale peptide/glykopeptide conjugates as synthetic vaccines for anti-tumor immunotherapy- Univ.-Prof. Dr. Edgar Schmitt,
- Prof. Dr. Pol Besenius
2017 - 2020
Functional clustering of T cell and other immune cell sub-phenotypes across plasticity and individualities of immune-mediated diseases- Univ.-Prof. Dr. Tobias Bopp